As of 04 Nov 2026 16:29 UTC. Status is always as stated in the latest recorded notice; the sources do not publish resolution, so nothing on this page says a medicine is back — see methodology.
Presentations, as stated in the latest recorded notice
Each line is re-expressed from MSN/2026/016 (25 Feb 2026): the product named, the status the source stated, and the expected-back phrase kept as written. Not the source's sentence, and not an observation of stock.
| Presentation | Status, as stated | Expected back, as stated | Stated in |
|---|---|---|---|
| Co-trimoxazole 40mg/200mg/5ml oral suspension sugar freeaffected product · inferred from phrasing | Out of stock, as stated | June 2026precision: a month · window end 30 Jun 2026, derived from “June 2026” | notice of 25 Feb 2026 |
| Co-trimoxazole 80mg/400mg/5ml oral suspensionaffected product · inferred from phrasing | Out of stock, as stated | to be confirmed, as stated | notice of 25 Feb 2026 |
| Co-trimoxazole 80mg/400mg and 160mg/800mg tabletsnamed by the source as remaining available · inferred from phrasing | Stated as available | — not stated for this line | notice of 25 Feb 2026 |
Protocol in force
No Serious Shortage Protocol matched to this name is in force on the NHSBSA register. Matching is by name until identifier coding lands.
Named in the source as remaining available
- Co-trimoxazole 80mg/400mg and 160mg/800mg tablets — named by the source as remaining available (inferred from phrasing)
Only names the source itself listed, as it listed them (source post ↗). No substitution, dosing or counselling advice is given here or implied.
Identifiers — Co-Trimoxazole
BNF chemical and SNOMED identifiers from NHSBSA Prescription Cost Analysis (Open Government Licence), matched by name (presentation name), confidence 0.90 — grouping under review where marked Release Jul 2026.
BNF SNOMED mapping, NHSBSA Copyright 2026; Prescription Cost Analysis (PCA) Monthly Administrative Data, NHSBSA Copyright 2026. This information is licenced under the terms of the Open Government Licence.
History
Notified short 3 times on record since 2023 — a recurring shortage spanning 2.3 years. We record when a shortage is declared, not when stock returns — the source doesn't publish that. An update sharing a reference counts as one episode.
| Issued | Notice | Kind | Tier | Reference |
|---|---|---|---|---|
| 25 Feb 2026 | Medicine Supply Notification: Co-trimoxazole 40mg/200mg/5ml oral suspension sugar free and Co-trimoxazole 80mg/400mg/5ml oral suspension | Supply notification | Tier 2 | MSN/2026/016 |
| 05 Jun 2024 | Medicine Supply Notification: Co-trimoxazole 40mg/200mg/5ml oral suspension sugar free | Supply notification | Tier 2 | MSN/2024/068 |
| 17 Nov 2023 | Medicine Supply Notification: Co-trimoxazole 40mg/200mg/5ml oral suspension sugar free and Co-trimoxazole 80mg/400mg/5ml oral suspension - Updated | Supply notification | Tier 3 | MSN/2023/103 |
Also recorded under
No other name appears in this medicine's notice titles. Grouping is by the head name in each title; brand and generic names may still sit on separate pages until identifier coding refines it — see the A–Z.
Scotland — separate record
NHS Scotland issues its own Medicine Supply Alert Notices. These match this medicine's name; they are shown beside, never added to, the England record.
- MSAN(2026)11 Co-trimoxazole 40mg/200mg/5ml oral suspension sugar free · issued 06 Mar 2026 · valid until early June 2026, as stated · matched by name PDF ↗
- MSAN(2024)33 Co-trimoxazole 40mg/200mg/5ml oral suspension sugar free · issued 11 Jun 2024 · valid until early September 2024, as stated · matched by name PDF ↗